|
Daehan Nupharm achieved sustained growth with second-quarter sales of 96.2 billion KRW, marking a 15% increase year-over-year.
Operating profit reached 12.7 billion KRW, and net profit climbed to 14.9 billion KRW, boosted by an 8.9 billion KRW gain related to a lawsuit victory.
The operating margin was 13%. The company plans to continue expanding with new product launches across pharmaceutical, health supplement, and veterinary medicine divisions. Notably, the pet product brand 'DiAnge' is set to aggressively expand sales activities following its launch in May.
New products for animal health and stress relief are also planned for release in the second half of the year. |